The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
BACKGROUNDThe prognosis for patients with atypical and malignant meningioma is guarded; whether the extent of resection is associated with survival‐based outcomes in this population remains poorly defined. This study investigated the association between gross total resection (GTR) and all‐cause mortality in patients with atypical and malignant meningioma.
METHODSThe Surveillance, Epidemiology, and...
Question What is the impact of cytotoxic chemotherapy on disease control and survival in the adult patient with progressive glioblastoma? Target population This recommendation applies to adults patients with progressive glioblastoma. Recommendations Level II Temozolomide is recommended as superior to procarbazine in patients with first relapse of glioblastoma after having received...
Question What is the influence of targeted medical therapies on disease control and survival in the adult patient with progressive glioblastoma? Targeted population This recommendation applies to adult patients with progressive glioblastoma RecommendationsLevel III Treatment with bevacizumab is recommended as it provides improved disease control compared to historical controls as...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.